Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.48 |
| ▸ | KIF11 | P52732 | 3/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.44 |
| ▸ | TUBB | P07437 | 2/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.44 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.44 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.44 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.44 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.44 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.44 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.44 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.44 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.44 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.44 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.44 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22802280 | 0.87 | IDO1 (0.50) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL22802341 | 0.86 | GFER (0.62) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL22802328 | 0.86 | IDO1 (0.48) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL22802340 | 0.86 | IDO1 (0.46) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL22802282 | 0.84 | IDO1 (0.62) | IDO1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL22802338 | 0.83 | DDR1 (0.47) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL31745770 | 0.83 | DDR1 (0.47) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL29609054 | 0.76 | KIF11 (0.49) | IDO1KIF11HTR1ADRD2HTR7 | |
| SCHEMBL22802289 | 0.76 | TUBB4A (0.48) | IDO1KIF11TUBB4ATUBBTUBA3C | |
| SCHEMBL31744683 | 0.76 | STING1 (0.45) | IDO1KIF11HTR1ADRD2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2025-01-21 | — | — | US | claimed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | claimed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | claimed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | claimed |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2025-01-21 | — | — | US | disclosed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | ZYX, IDO1, CRY1 | IDO1 2/4885KIF11 4305/4885TUBB4A 2312/4885 |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | FPR1, FPR3, ARG1 | IDO1 23/4885KIF11 4098/4885TUBB4A 2901/4885 |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | IDO1 38/4885KIF11 2452/4885TUBB4A 2340/4885 |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | FPR1, FPR3, ARG1 | IDO1 23/4885KIF11 4098/4885TUBB4A 2901/4885 |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | IDO1 38/4885KIF11 2452/4885TUBB4A 2340/4885 |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | ZYX, IDO1, CRY1 | IDO1 2/4885KIF11 4305/4885TUBB4A 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.